BIOMARKER-BASED CANCER THERAPY PERSONALIZATION

被引:0
|
作者
Yamada, T. [1 ]
Masuda, M. [1 ]
Honda, K. [1 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Chemotherapy & Clin Res, Chiba, Japan
关键词
D O I
10.1093/annonc/mds564
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:54 / 54
页数:1
相关论文
共 50 条
  • [41] Biomarker-based risk scores in atrial fibrillation
    Hijazi, Ziad
    Mills, Nicholas L.
    Mueller, Christian
    [J]. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2021, 10 (09) : 1084 - 1085
  • [42] Validation of Biomarker-Based Risk Prediction Models
    Taylor, Jeremy M. G.
    Ankerst, Donna P.
    Andridge, Rebecca R.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (19) : 5977 - 5983
  • [43] IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy
    Xin Chen
    Jingyi Zhang
    Liyun Jiang
    Fangrong Yan
    [J]. BMC Medical Research Methodology, 23
  • [44] Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy
    Satoshi Yamaga
    Shinichiro Ohshimo
    Nobuaki Shime
    Saad Nseir
    Boualem Sendid
    Anahita Rouzé
    [J]. Intensive Care Medicine, 2018, 44 : 399 - 400
  • [45] Era of biomarker-based disease risk management
    Yukihito Higashi
    [J]. Hypertension Research, 2023, 46 : 893 - 895
  • [46] Immune biomarker-based enrichment in sepsis trials
    Spinetti, Thibaud
    Meisel, Christian
    von Gunten, Stephan
    Schefold, Joerg C.
    [J]. CRITICAL CARE, 2020, 24 (01):
  • [47] A New General Biomarker-based Incidence Estimator
    Kassanjee, Reshma
    McWalter, Thomas A.
    Baernighausen, Till
    Welte, Alex
    [J]. EPIDEMIOLOGY, 2012, 23 (05) : 721 - 728
  • [48] IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy
    Chen, Xin
    Zhang, Jingyi
    Jiang, Liyun
    Yan, Fangrong
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [49] Bayesian Two-Stage Biomarker-Based Adaptive Design for Targeted Therapy Development
    Gu X.
    Chen N.
    Wei C.
    Liu S.
    Papadimitrakopoulou V.A.
    Herbst R.S.
    Lee J.J.
    [J]. Statistics in Biosciences, 2016, 8 (1) : 99 - 128
  • [50] Era of biomarker-based disease risk management
    Higashi, Yukihito
    [J]. HYPERTENSION RESEARCH, 2023, 46 (04) : 893 - 895